Literature DB >> 6881185

High-dose gallium imaging in lymphoma.

K C Anderson, R C Leonard, G P Canellos, A T Skarin, W D Kaplan.   

Abstract

The role of gallium-67 imaging in the management of patients with lymphoma, traditionally assessed using low tracer doses and the rectilinear scanner, was assessed when using larger doses (7 to 10 mCi) and a triple-peak Anger camera. Gallium scan results in 51 patients with non-Hodgkin's lymphoma and 21 patients with Hodgkin's disease were compared with simultaneous radiologic, clinical, and histopathologic reports. Subsequent disease course was also evaluated in light of radionuclide findings. Sensitivity and specificity of the scans were 0.90 or greater for both non-Hodgkin's lymphoma and Hodgkin's disease, and overall accuracy by site was 96 percent. Although there are insufficient numbers of pretreatment scans to allow any conclusions, our data suggest that newer approaches to gallium scanning in treated patients are (1) highly specific in all lymphomas and most sensitive in high-grade non-Hodgkin's lymphoma and Hodgkin's disease; (2) valuable in assessing the mediastinum in both non-Hodgkin's lymphoma and Hodgkin's disease; and (3) helpful adjuncts to computed tomographic scanning and ultrasonography in assessing abdominal node disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881185     DOI: 10.1016/0002-9343(83)91212-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.

Authors:  M Bendini; C Zuiani; M Bazzocchi; G Dalpiaz; F Zaja; E Englaro
Journal:  MAGMA       Date:  1996 Sep-Dec       Impact factor: 2.310

Review 2.  Paediatric nuclear medicine.

Authors:  A Piepsz; I Gordon; K Hahn
Journal:  Eur J Nucl Med       Date:  1991

Review 3.  Recent advances in the diagnosis and therapy of Richter's syndrome.

Authors:  Ronan Swords; John Bruzzi; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 4.  Oncology.

Authors:  J S Malpas
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

5.  Does leukocyte scintigraphy answer the need for a more widely available radiopharmaceutical that can detect and assess the proliferative state of lymphoma?

Authors:  C Van de Wiele; M Simons; L Noens; R A Dierckx
Journal:  Eur J Nucl Med       Date:  1996-04

Review 6.  Current role of gallium scanning in the management of lymphoma.

Authors:  A F McLaughlin; M A Magee; R Greenough; K C Allman; A E Southee; S R Meikle; B F Hutton; D E Joshua; G J Bautovich; J G Morris
Journal:  Eur J Nucl Med       Date:  1990

7.  Lymphoma imaging with a new technetium-99m labelled antibody, LL2.

Authors:  S Murthy; R M Sharkey; D M Goldenberg; R E Lee; C M Pinsky; H J Hansen; K Burger; L C Swayne
Journal:  Eur J Nucl Med       Date:  1992

Review 8.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

9.  Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.

Authors:  P Ziegels; M Nocaudie; D Huglo; M Deveaux; L Detourmignies; E Wattel; X Marchandise
Journal:  Eur J Nucl Med       Date:  1995-02

10.  67Ga scan for evaluating response to therapy in malignant lymphoma.

Authors:  K Koizumi; H Ogata; G Uchiyama; T Araki; T Hihara; S Monzawa; K Kachi; M Matsusako
Journal:  Eur J Nucl Med       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.